|
PIGY expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.14199991077635E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.38529973550783E-10 |
| Normal-vs-Stage2 |
1.314190E-02 |
| Normal-vs-Stage3 |
5.40510000091032E-08 |
| Normal-vs-Stage4 |
2.887700E-02 |
| Stage1-vs-Stage2 |
1.751590E-01 |
| Stage1-vs-Stage3 |
5.085200E-01 |
| Stage1-vs-Stage4 |
4.798800E-01 |
| Stage2-vs-Stage3 |
1.055820E-01 |
| Stage2-vs-Stage4 |
8.023000E-01 |
| Stage3-vs-Stage4 |
2.695600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.46790382468976E-11 |
| Normal-vs-AfricanAmerican |
3.98990000000099E-05 |
| Normal-vs-Asian |
8.775900E-02 |
| Caucasian-vs-AfricanAmerican |
3.108100E-02 |
| Caucasian-vs-Asian |
9.515400E-01 |
| AfricanAmerican-vs-Asian |
4.455000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.85379514358897E-11 |
| Normal-vs-Female |
1.22780000000322E-06 |
| Male-vs-Female |
1.062560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.42120000049084E-07 |
| Normal-vs-Extreme_Weight |
4.76249994996181E-09 |
| Normal-vs-Obese |
5.9690999998363E-07 |
| Normal-vs-Extreme_Obese |
3.387700E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.156400E-01 |
| Normal_Weight-vs-Obese |
7.917800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.603600E-01 |
| Extreme_Weight-vs-Obese |
6.776600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.916600E-01 |
| Obese-vs-Extreme_Obese |
8.472800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.829000E-04 |
| Normal-vs-Age(41-60Yrs) |
2.37570000338749E-08 |
| Normal-vs-Age(61-80Yrs) |
4.65499860879959E-11 |
| Normal-vs-Age(81-100Yrs) |
3.21120000001951E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.593800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.009600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.367800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.735610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.527600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.759600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.81410003369842E-09 |
| Normal-VS-Type2 PRCC |
6.68565203199023E-12 |
| Normal-VS-KIRP CIMP |
2.508200E-02 |
| Normal-VS-Unclassified PRCC |
7.70779995384885E-10 |
| Type1 PRCC-VS-Type2 PRCC |
1.792350E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.744600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.653800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.749700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.870000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.166200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.37019967489027E-10 |
| Normal-vs-N1 |
1.07279999994603E-06 |
| Normal-vs-N2 |
2.394000E-01 |
| N0-vs-N1 |
3.861600E-01 |
| N0-vs-N2 |
6.252600E-01 |
| N1-vs-N2 |
9.155200E-01 |
|
|
